Archives: Agenda

Technology Spotlight: Unlocking the potential of healthcare data


We will explore how AI  and Real-World Data (RWD) are reshaping clinical trials. We will delve into how our Data Space Platform addresses industry challenges by ensuring efficient, secure, and structured access to clinical data within the framework of the European Health Data Space (EHDS). Our technology, powered by Artificial Intelligence and Natural Language Processing (NLP), extracts, structures, and harmonizes unstructured clinical data, enabling seamless interoperability and maximizing its value for research. As data mediators, we bridge the gap between data providers and the industry, accelerating patient identification, optimizing recruitment, and enhancing data quality in clinical trials.
Through concrete use cases, we will demonstrate how our platform has driven the success of clinical trials by providing fast and reliable access to clinical data while aligning with European regulations and standards.

Setting the Tone for the Patient and Site Journey

Patient advocacy groups have more influence on study design. The industry is investing in Chief Patient Officer roles. Site networks are consolidating. CROs are expanding and buying sites.

What’s missing, however, is a focus on enhancing the patient/site relationship.

This session explores the state of technology that supports the patient and site experience, successes/gaps, and concrete next steps.

Panel Discussion Integrating the Patient Voice in Protocol Design: Balancing Rigor, Feasibility, and Centricity

Incorporating the patient perspective into clinical trial protocol design and endpoint selection is essential for ensuring that trials are relevant and meaningful. However, this integration presents challenges, including finding common ground among stakeholders and navigating the balance between scientific rigor and feasibility. This session will explore how pharma companies can streamline protocols while maintaining their integrity and enhancing patient engagement

  • Understand the importance of the patient voice in clinical trial design and endpoint selection.
  • Identify challenges in balancing scientific and Regulatory rigor, feasibility, and patient-centricity.
  • Explore strategies for creating streamlined protocols without compromising essential data collection.
  • Discuss best practices for enhancing collaboration within trial teams to facilitate patient-centered design

Moderator: Estrella Garcia, Executive Global Clinical Operations Director, ALMIRALL

Panellists: Denis Costello, Director at CML Advocates Network & Board Member

Laia Bisbal Arnal, Open Classroom Coordinator, EUPATI